Business Description
Ascentage Pharma Group International
ISIN : KYG0519B1023
Compare
Compare
Traded in other countries / regions
06855.Hong Kong36X.GermanyASPHF.USA IPO Date
2019-10-28Description
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.6 | |||||
| Equity-to-Asset | 0.02 | |||||
| Debt-to-Equity | 29.72 | |||||
| Debt-to-EBITDA | -2.22 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -2.48 | |||||
| Beneish M-Score | -1.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 133 | |||||
| 3-Year EBITDA Growth Rate | 6.5 | |||||
| 3-Year EPS without NRI Growth Rate | 1 | |||||
| 3-Year FCF Growth Rate | 13.8 | |||||
| 3-Year Book Growth Rate | -62.8 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.4 | |||||
| 9-Day RSI | 36.51 | |||||
| 14-Day RSI | 41.6 | |||||
| 6-1 Month Momentum % | -29.71 | |||||
| 12-1 Month Momentum % | -15.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.44 | |||||
| Quick Ratio | 1.42 | |||||
| Cash Ratio | 1.14 | |||||
| Days Inventory | 122.83 | |||||
| Days Sales Outstanding | 155.11 | |||||
| Days Payable | 867.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.7 | |||||
| Shareholder Yield % | -8.33 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 86.24 | |||||
| Operating Margin % | -393.11 | |||||
| Net Margin % | -416.98 | |||||
| FCF Margin % | -352.69 | |||||
| ROE % | -260.12 | |||||
| ROA % | -33.42 | |||||
| ROIC % | -49.42 | |||||
| ROC (Joel Greenblatt) % | -111.38 | |||||
| ROCE % | -43.05 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 20.99 | |||||
| PB Ratio | 79.22 | |||||
| EV-to-EBIT | -6.9 | |||||
| EV-to-EBITDA | -7.13 | |||||
| EV-to-Revenue | 26.02 | |||||
| EV-to-FCF | -7.88 | |||||
| Earnings Yield (Greenblatt) % | -14.49 | |||||
| FCF Yield % | -16.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ascentage Pharma Group International Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 242.802 | ||
| EPS (TTM) (HK$) | -3.588 | ||
| Beta | 1.03 | ||
| Volatility % | 50.94 | ||
| 14-Day RSI | 41.6 | ||
| 14-Day ATR (HK$) | 1.009845 | ||
| 20-Day SMA (HK$) | 19.263 | ||
| 12-1 Month Momentum % | -15.59 | ||
| 52-Week Range (HK$) | 15.42 - 28.15 | ||
| Shares Outstanding (Mil) | 290.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ascentage Pharma Group International Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ascentage Pharma Group International Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ascentage Pharma Group International Frequently Asked Questions
What is Ascentage Pharma Group International(HKSE:06855)'s stock price today?
The current price of HKSE:06855 is HK$18.22. The 52 week high of HKSE:06855 is HK$28.15 and 52 week low is HK$15.42.
When is next earnings date of Ascentage Pharma Group International(HKSE:06855)?
The next earnings date of Ascentage Pharma Group International(HKSE:06855) is 2024-08-21 Est..
Does Ascentage Pharma Group International(HKSE:06855) pay dividends? If so, how much?
Ascentage Pharma Group International(HKSE:06855) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers